Dexcom's G6 continuous glucose monitor (CGM) is being used by astronauts on the Polaris Dawn mission to study spaceflight's impact on glucose regulation and overall metabolic health. Partnering with Labfront, a data collection and analysis platform, Dexcom will provide advanced analytics to understand how factors like microgravity, fluid shifts, and blood flow restriction exercises affect glucose dynamics. This five-day mission includes 40 experiments focused on key biomarkers for space health, offering insights into metabolic responses and potential applications for diabetes management in extreme environments.

For more information, visit Drug Delivery Business.